The recent 72nd World Health Assembly – the May 2019 edition of WHO’s annual global health gathering in Geneva – offered unusually powerful windows into the advances of traditional, complementary and integrative medicine (TCIM) internationally. A WHO progress report detailed the expanding regulatory context for traditional medicine practice. Exemplar nations participated in a TCIM briefing session (all presentations available publicly). In parallel, the approval of a separate WHO initiative, long in development, to include Traditional Chinese Medicine (TCM) codes in the 11th version of WHO’s international classification of diseases (ICD-11) received major push back.
The US medical industry has a motivation problem when it comes to the central role of food in health. Kale does not emit a flock of attractive sales people to detail doctor offices. Organics lack the financial clout to fund JAMA. Brown rice gets failure grades on inviting doctors to conferences in tropical zones. Fruits and vegetables seem to have missed out entirely on the whole marketing side of competing with the pharma-device predilections of the $3.3-trillion medical industry.